PMP22 and demyelinating polyneuropathy: A possible explanation is that those mutations produce a “partial loss-of-function” of PMP22. Mice in which both Pmp22 alleles have been inactivated exhibit severe clinical weakness, markedly reduced nerve conduction velocity, and a severe demyelinating peripheral neuropathy in pathology (12, 31).